Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from MedAdvisor Limited ( (AU:MDR) ).
MedAdvisor Limited has announced the issuance of 1,750,000 fully paid ordinary securities to be quoted on the Australian Securities Exchange (ASX) on November 6, 2025. This move is part of a previously announced transaction and is expected to impact the company’s market presence by increasing its available securities, potentially enhancing liquidity and investor interest.
The most recent analyst rating on (AU:MDR) stock is a Hold with a A$0.10 price target. To see the full list of analyst forecasts on MedAdvisor Limited stock, see the AU:MDR Stock Forecast page.
More about MedAdvisor Limited
MedAdvisor Limited operates in the healthcare industry, providing digital health solutions primarily focused on medication management. The company offers platforms and services that enhance the efficiency of medication adherence and management for patients, healthcare professionals, and pharmacies.
Average Trading Volume: 845,769
Technical Sentiment Signal: Sell
Current Market Cap: A$16.45M
See more data about MDR stock on TipRanks’ Stock Analysis page.